Handelsbanken Fonder AB - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$253
-24.5%
10,5000.0%0.00%
-50.0%
Q2 2023$335
+16.3%
10,500
+11.7%
0.00%0.0%
Q1 2023$288
-21.7%
9,4000.0%0.00%0.0%
Q4 2022$368
-99.8%
9,400
+113.6%
0.00%
+100.0%
Q3 2022$210,000
-58.8%
4,400
-50.6%
0.00%
-66.7%
Q1 2022$510,000
-28.1%
8,9000.0%0.00%0.0%
Q4 2021$709,000
-0.6%
8,900
+8.5%
0.00%
-25.0%
Q3 2021$713,000
-32.4%
8,2000.0%0.00%
-33.3%
Q2 2021$1,055,000
+96.8%
8,200
+22.4%
0.01%
+100.0%
Q1 2021$536,000
-2.0%
6,7000.0%0.00%0.0%
Q4 2020$547,0006,7000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders